Table III.
Death (n = 22) | Survival (n = 114) | Value of p | |||
---|---|---|---|---|---|
Age [years] | Mean (from-to) | 54.57 ±8.7 (38-69) | 53.91 ±10.7 (18-73) | NS | |
Sex | Men/Women | n | 4/18 | 40/74 | NS |
Urgent indications | n | 5 | 20 | NS | |
NYHA class III-IV | n | 20 | 48 | < 0.001 | |
Time from PVR [months] mean, med., from-to | 105.9 ±60, 114, 0-230 | < 0.02 | |||
≤ 30 days; n | 7 | 8 | |||
31-180 days; n | 12 | 7 | |||
> 180 days; n | 3 | 99 | |||
One valve | n | 20 | 93 | NS | |
Two valves | n | 2 | 21 | NS | |
PV mechanical/bioprosthesis | n | 15/7 | 45/69 | < 0.02 | |
Additional procedures | n | 6 | 23 | NS | |
Prosthetic valve dysfunction* | n | 15 | 45 | - | |
Disc blockage | n | 7 | 23 | NS | |
Paravalvular leak | n | 5 | 12 | NS | |
Structural degeneration | n | 2 | 4 | NS | |
Other | n | 1 | 6 | NS | |
Atrial fibrillation | n | 21 | 84 | < 0.01 | |
Ejection fraction < 55% | n | 11 | 40 | NS |
PVI - prosthetic valve implantation,
refers to patients operated on for mechanical prosthetic valve dysfunction